Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences
BRIEF-10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences Aug 28 (Reuters) - 10x Genomics TXG.O:
10X GENOMICS WINS PATENT INFRINGEMENT VERDICT AGAINST PARSE BIOSCIENCES
10X GENOMICS - JURY FINDS PARSE BIOSCIENCES WILLFULLY INFRINGED THREE SCALE BIOSCIENCES PATENTS
10X GENOMICS - JURY AWARDS CO OVER $4.80 MILLION IN DAMAGES FOR INFRINGING SALES FEB 2021-JUNE 30, 2026
10X GENOMICS - TO SEEK ENHANCED DAMAGES AND PERMANENT INJUNCTION AGAINST PARSE IN U.S.
Source text: ID:nPn2lXqdya
Further company coverage: [TXG.O QIA.DE]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on QIAGEN
See all newsLab testing LBO offers murky result for both sides
Deals of the day-Mergers and acquisitions
Press Digest: Financial Times - October 22
Brief: Qiagen And Eqt Private Equity Announce Agreement On A Recommended Voluntary All-Cash Public Takeover Offer
EQT to buy molecular testing firm Qiagen for $10.8 billion (updated)